|
1
|
Leemans CR, Braakhuis BJ and Brakenhoff
RH: The molecular biology of head and neck cancer. Nat Rev Cancer.
11:9–22. 2011. View Article : Google Scholar
|
|
2
|
Hasegawa H, Kusumi Y, Asakawa T, Maeda M,
Oinuma T, Furusaka T, Oshima T and Esumi M: Expression of von
hippel-lindau tumor suppressor protein (pVHL) characteristic of
tongue cancer and proliferative lesions in tongue epithelium. BMC
Cancer. 17:3812017. View Article : Google Scholar :
|
|
3
|
Scully C, Field JK and Tanzawa H: Genetic
aberrations in oral or head and neck squamous cell carcinoma 3:
Clinico-pathological applications. Oral Oncol. 36:404–413. 2000.
View Article : Google Scholar
|
|
4
|
de Hoon M, Shin JW and Carninci P:
Paradigm shifts in genomics through the FANTOM projects. Mamm
Genome. 26:391–402. 2015. View Article : Google Scholar :
|
|
5
|
Xin Y, Li Z, Shen J, Chan MT and Wu WK:
CCAT1: A pivotal oncogenic long non-coding RNA in human cancers.
Cell Prolif. 49:255–260. 2016. View Article : Google Scholar
|
|
6
|
Guo X and Hua Y: CCAT1: An oncogenic long
noncoding RNA in human cancers. J Cancer Res Clin Oncol.
143:555–562. 2017. View Article : Google Scholar
|
|
7
|
Yang YT, Wang YF, Lai JY, Shen SY, Wang F,
Kong J, Zhang W and Yang HY: Long non-coding RNA UCA1 contributes
to the progression of oral squamous cell carcinoma by regulating
the WNT/β-catenin signaling pathway. Cancer Sci. 107:1581–1589.
2016. View Article : Google Scholar :
|
|
8
|
Wang L, Ye S, Wang J, Gu Z, Zhang Y, Zhang
C and Ma X: HuR stabilizes lnc-Sox5 mRNA to promote tongue
carcinogenesis. Biochemistry (Mosc). 82:438–445. 2017. View Article : Google Scholar
|
|
9
|
Zhang TH, Liang LZ, Liu XL, Wu JN, Su K,
Chen JY, Zheng QY, Huang HZ and Liao GQ: Long non-coding RNA MALAT1
interacts with miR-124 and modulates tongue cancer growth by
targeting JAG1. Oncol Rep. 37:2087–2094. 2017. View Article : Google Scholar
|
|
10
|
Zhang H, Zhao L, Wang YX, Xi M, Liu SL and
Luo LL: Long non-coding RNA HOTTIP is correlated with progression
and prognosis in tongue squamous cell carcinoma. Tumour Biol.
36:8805–8809. 2015. View Article : Google Scholar
|
|
11
|
Arteaga CL: Overview of epidermal growth
factor receptor biology and its role as a therapeutic target in
human neoplasia. Semin Oncol. 29 5 Suppl 14:S3–S9. 2002. View Article : Google Scholar
|
|
12
|
Herbst RS: Review of epidermal growth
factor receptor biology. Int J Radiat Oncol Biol Phys. 59 2
Suppl:S21–S26. 2004. View Article : Google Scholar
|
|
13
|
Gao JW, Zhan P, Qiu XY and Song Y:
Erlotinib-based doublet targeted therapy versus erlotinib alone in
previously treated advanced non-small-cell lung cancer: A
meta-analysis from 24 randomized controlled trials. Oncotarget.
32:2017.
|
|
14
|
Walker F, Abramowitz L, Benabderrahmane D,
Duval X, Descatoire V, Hénin D, Lehy T and Aparicio T: Growth
factor receptor expression in anal squamous lesions: Modifications
associated with oncogenic human papillomavirus and human
immunodeficiency virus. Hum Pathol. 40:1517–1527. 2009. View Article : Google Scholar
|
|
15
|
Alterio D, Marvaso G, Maffini F, Gandini
S, Chiocca S, Ferrari A, Preda L, Rocca MC, Lepanto D, Fodor C, et
al: Role of EGFR as prognostic factor in head and neck cancer
patients treated with surgery and postoperative radiotherapy:
Proposal of a new approach behind the EGFR overexpression. Med
Oncol. 34:1072017. View Article : Google Scholar
|
|
16
|
Jonsson Lindell E, Nylander K, Hallén L
and Laurell G: Immunohistochemical analysis of EGFR and hyaluronan
in tongue cancer and the development of regional recurrence in
patients initially diagnosed N0. Acta Otolaryngol. 137:877–882.
2017. View Article : Google Scholar
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
18
|
Jiang R, Tang J, Chen Y, Deng L, Ji J, Xie
Y, Wang K, Jia W, Chu WM and Sun B: The long noncoding RNA lnc-EGFR
stimulates T-regulatory cells differentiation thus promoting
hepatocellular carcinoma immune evasion. Nat Commun. 8:151292017.
View Article : Google Scholar :
|
|
19
|
Islam S, Qi W, Morales C, Cooke L, Spier
C, Weterings E and Mahadevan D: Disruption of aneuploidy and
senescence induced by aurora inhibition promotes intrinsic
apoptosis in double hit or double expressor diffuse large b-cell
lymphomas. Mol Cancer Ther. doi: 10.1158/1535-7163. 2017.
View Article : Google Scholar
|
|
20
|
Li HH, Su JH, Chiu CC, Lin JJ, Yang ZY,
Hwang WI, Chen YK, Lo YH and Wu YJ: Proteomic investigation of the
sinulariolide-treated melanoma cells A375: Effects on the cell
apoptosis through mitochondrial-related pathway and activation of
caspase cascade. Mar Drugs. 11:2625–2642. 2013. View Article : Google Scholar :
|
|
21
|
Liu JY, Liu Z, Wang DM, Li MM, Wang SX,
Wang R, Chen JP, Wang YF and Yang DP: Induction of apoptosis in
K562 cells by dicyclohexylammonium salt of hyperforin through a
mitochondrial-related pathway. Chem Biol Interact. 190:91–101.
2011. View Article : Google Scholar
|
|
22
|
Kerr JF, Wyllie AH and Currie AR:
Apoptosis: A basic biological phenomenon with wide-ranging
implications in tissue kinetics. Br J Cancer. 26:239–257. 1972.
View Article : Google Scholar :
|
|
23
|
Wajant H: The Fas signaling pathway: More
than a paradigm. Science. 296:1635–1636. 2002. View Article : Google Scholar
|
